ALPHA TRIBE

Jubilant Pharmova LimitedUpdates, 26-06-2026: General Updates

26-06-2026 | 12:23 am

Jubilant Pharmova's subsidiary, Jubilant Generics, secured USFDA tentative approval for Pantoprazole Sodium Delayed Release Oral Suspension. Final approval awaits the Reference Listed Drug's patent expiry, signaling future market entry.

No comments yet. Be the first to comment!

All announcements from Jubilant Pharmova Limited